SCHEMBL28839896

SCHEMBL28839896

CCc1cc(N)ccc1C1CCN(OC(=O)C(C)(C)C)CC1

nearest known ligand 0.34

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 1/20 0.34
SLC9A1 P19634 6/20 0.33
CYP2C9 P11712 5/20 0.33
CYP2C19 P33261 4/20 0.33
CYP3A4 P08684 4/20 0.33
HTR1D P28221 1/20 0.33
HTR1B P28222 1/20 0.33
KCNH2 Q12809 1/20 0.33
ACHE P22303 3/20 0.33
HTR4 Q13639 3/20 0.33
MAPK1 P28482 1/20 0.32
CHRNB2 P17787 1/20 0.32
CHRNA4 P43681 1/20 0.32
GPR119 Q8TDV5 2/20 0.32
TRPC6 Q9Y210 1/20 0.31
BTK Q06187 2/20 0.31
ALDH1A1 P00352 1/20 0.31
LMNA P02545 1/20 0.31
CYP2D6 P10635 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28024448 0.85 OPRL1 (0.36) NR1H2SLC9A1CYP2C9CYP2C19CYP3A4
SCHEMBL28024911 0.84 GPR119 (0.40) NR1H2SLC9A1CYP2C9CYP2C19CYP3A4
SCHEMBL28128282 0.83 GUCY1A1 (0.33) SLC9A1CYP2C9CYP2C19CYP3A4KCNH2
SCHEMBL28128251 0.82 RBP4 (0.43) SLC9A1CYP2C9CYP2C19CYP3A4KCNH2
SCHEMBL17397759 0.82 MAPT (0.49) NR1H2CYP2C9CYP2C19CYP3A4MAPK1
SCHEMBL27948292 0.82 SLC9A1 (0.48) SLC9A1CYP2C9CYP2C19CYP3A4KCNH2
SCHEMBL27842061 0.79 F2 (0.40)
SCHEMBL27682015 0.79 RIPK1 (0.39) CHRNB2CHRNA4
SCHEMBL17395599 0.78 SLC9A1 (0.38) SLC9A1CYP2C9CYP2C19CYP3A4HTR1D
SCHEMBL27949194 0.78 HDAC1 (0.38) CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106470985-A Indane and indoline derivatives as soluble guanylate cyclase activators and uses thereof 诺华股份有限公司 2017-03-01 CN disclosed